10-3PS Prostaglandin D2 (PGD2): Therapeutic Implications

Wednesday, 7 December 2011: 09:25 - 09:50
Costa Maya (Cancún Center)

Andrew Wardlaw , Infection Immunity and Inflammation, Institute for Lung Health, Leicester, United Kingdom